Articles > Newspapers > International Newspapers, Local Markets A-Lh > PTI - The Press Trust of India Ltd. news wires > September 2006

Article: Elli Lilly launches anti-cancer drug 'Alimta' in India.

Article from:
PTI - The Press Trust of India Ltd.
Article date:
September 18, 2006
Copyright

Elli Lilly launches anti-cancer drug 'Alimta' in India

New Delhi, Sep 18 (PTI) US-based pharma company Eli Lilly today launched its anti-cancer drug, 'Alimta', in India.

The new drug would be used in combination with cisplatin for the treatment of patients with malignant pleural mesothelioma, a company statement said here.

Alimta has also been approved as second line treatment for non small cell lung cancer, it said.

The product was first approved in 2004 in the US and since then it has been approved in more than 70 countries and ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: INDIAN BOARD CONSIDERS ELLI LILLY RANBAXY, ABBOTT'S ...
AsiaPulse News;  March 30, 2001 ;     403 words ...NEW DELHI, March 30 Asia Pulse - Proposals of leading pharma company Elli Lilly Ranbaxy and infotech major IBM India were among the 65 proposals condsidered by the Foreign Investment Promotion Board (FIPB ...

Article: This Essential Report on Cancer Drug Resistance is ...
M2 Presswire;  September 17, 2008 ;     700+ words ... ... and Markets: This Essential Report on Cancer Drug Resistance is Available Now(C)1994 ... researchandmarkets.com/research/e19565/cancer_drug_resist) has announced the addition of the "Cancer Drug Resistance" report to their offering ...

Article: Research and Markets: This Essential Report on Cancer ...
Business Wire;  September 17, 2008 ;     700+ words ... ... researchandmarkets.com/research/1e8682/cancer_drug_resist) has announced the addition of the "Cancer Drug Resistance" report to their offering ... detailed and comprehensive review of cancer drug resistance Drug resistance is the single ...

Article: Echo health - 'Cost is not the issue in cancer drug ...
The Northern Echo;  June 8, 2007 ;     700+ words ... ... director of the North of England Cancer Drug Network - which includes a sub ... known as the NorthEast and Cumbria Cancer Drug Approvals Group - insists that ... back the revolutionary breast cancer drug Herceptin and has gone out on ...

Article: Cancer drug batimastat starts pivotal Phase III ...
Business Wire;  November 15, 1994 ;     700+ words ... ... Phase III efficacy trials with its new cancer drug, batimastat, and the start of human clinical testing of its new oral anti-cancer drug, BB-2516. Batimastat - Batimastat ... patients at all stages of disease." -0- Cancer drug batimastat starts pivotal Phase III ...

Article: Firm vows to cut cancer drug cost
The Northern Echo;  June 5, 2007 ;     700+ words ... ... Pfizer, the maker of kidney cancer drug Sutent, has yet to publicly announce ... Excellence (Nice) and the maker of a cancer drug called Velcade, which means the ... will only pay for the bone marrow cancer drug if it works. Under the scheme ...

Article: Lung Cancer Drug Pipeline Update 2009.
M2 Presswire;  March 4, 2009 ;     700+ words ... ... March 2009-Research and Markets: Lung Cancer Drug Pipeline Update 2009(C)1994-2009 ... researchandmarkets.com/research/385a31/lung_cancer_drug_p) has announced the addition of the "Lung Cancer Drug Pipeline Update 2009" report to their ...

Article: Renal Cancer Drug Pipeline Update 2009.
M2 Presswire;  March 2, 2009 ;     680 words ... ... 2009-Research and Markets: Renal Cancer Drug Pipeline Update 2009(C)1994-2009 ... com/research/413789/renal_cancer_drug) has announced the addition of the "Renal Cancer Drug Pipeline Update 2009" report to their ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives